Angiotensin Converting Enzyme 2 News and Research

RSS
NSAID–antihypertensive combinations may risk kidney damage

NSAID–antihypertensive combinations may risk kidney damage

Myocardial infarction mortality rates decrease by 44% over the last 15 years in Argentina

Myocardial infarction mortality rates decrease by 44% over the last 15 years in Argentina

Surprising new roles for angiotensin converting enzyme

Surprising new roles for angiotensin converting enzyme

Lack of evidence to recommend routine screening for chronic kidney disease

Lack of evidence to recommend routine screening for chronic kidney disease

Women with heart attack symptoms receive lower quality of care than men

Women with heart attack symptoms receive lower quality of care than men

Molecular explanation for increased susceptibility to intestinal inflammation in malnutrition

Molecular explanation for increased susceptibility to intestinal inflammation in malnutrition

Why is the incidence of gout increasing?

Why is the incidence of gout increasing?

ACE inhibitors ‘protect against pneumonia’

ACE inhibitors ‘protect against pneumonia’

Harmonizing prescription drug plans can help save millions of dollars

Harmonizing prescription drug plans can help save millions of dollars

First clinical trial to test cardiac drug regimen for DMD

First clinical trial to test cardiac drug regimen for DMD

Maternal factors associated with fetal growth restriction

Maternal factors associated with fetal growth restriction

Dyax to discontinue ecallantide Phase 2 trial for ACE inhibitor-induced angioedema

Dyax to discontinue ecallantide Phase 2 trial for ACE inhibitor-induced angioedema

ACE inhibitors or ARBs could treat and prevent PTSD

ACE inhibitors or ARBs could treat and prevent PTSD

Women with chronic heart failure survive longer than their male counterparts

Women with chronic heart failure survive longer than their male counterparts

High blood pressure due to stress maybe due to the immune system

High blood pressure due to stress maybe due to the immune system

Concert commences dosing in CTP-499 Phase 2 clinical trial for diabetic nephropathy

Concert commences dosing in CTP-499 Phase 2 clinical trial for diabetic nephropathy

Dyax fourth quarter total revenues decrease to $8.5 million

Dyax fourth quarter total revenues decrease to $8.5 million

Combination of key guideline-recommended heart failure therapies improve survival odds

Combination of key guideline-recommended heart failure therapies improve survival odds

Lab-based treatment reminders may not be effective for CKD patients

Lab-based treatment reminders may not be effective for CKD patients

Researchers publish first detailed figures that show risk of Rasilez and ACE inhibitors or ARBs

Researchers publish first detailed figures that show risk of Rasilez and ACE inhibitors or ARBs

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.